Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Child
Child, Preschool
DNA, Viral
Female
Genotype
Hepatitis B e Antigens
/ blood
Hepatitis B virus
/ genetics
Hepatitis B, Chronic
/ blood
Humans
Infant
Male
Middle Aged
Population Groups
Public Health Surveillance
Seroepidemiologic Studies
Viral Load
Young Adult
e antigen
hepatitis B
natural history
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
28
01
2019
revised:
07
03
2019
accepted:
15
03
2019
pubmed:
12
4
2019
medline:
14
7
2020
entrez:
12
4
2019
Statut:
ppublish
Résumé
Hepatitis B e antigen (HBeAg) is an important serological marker of hepatitis B virus (HBV) infection and is associated with higher levels of viraemia, increased risk of infectivity to others and increased risk of hepatocellular carcinoma. We analysed HBeAg status in a large cohort of adults and children enrolled in Cohort Studies of the Hepatitis B Research Network, long-term natural history studies of chronic HBV infection. A cross-sectional analysis examined factors associated with HBeAg positivity, including demographic and virologic data, across the age spectrum. Among 2241 enrolled participants who met criteria for this analysis, 825 (37%) were seropositive for HBeAg. The prevalence of HBeAg was lower in those with older age, ranging from 85% among those up to 10 years of age to only 12% among those older than 50 years. In addition to age, both race and HBV genotype were independently associated with HBeAg positivity. There was a significant interaction between age and race; the prevalence of HBeAg was significantly higher among Asians > 10-30 years old vs Whites or Blacks who were >10 to 30 years old and those infected with HBV genotype C. Conversely, the presence of the basal core promoter and precore variants was associated with significantly lower prevalence of HBeAg, even when adjusted for age, race and genotype. These data will provide a better understanding of factors associated with seropositivity for HBeAg and may lead to better strategies for preventing HBV infection and broader indications for antiviral therapy.
Identifiants
pubmed: 30974509
doi: 10.1111/jvh.13104
pmc: PMC6592737
mid: NIHMS1023360
doi:
Substances chimiques
DNA, Viral
0
Hepatitis B e Antigens
0
Banques de données
ClinicalTrials.gov
['NCT01263587', 'NCT01263600']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
856-865Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK082916
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001111
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082943
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082923
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000058
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082867
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082874
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024986
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082919
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082927
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082872
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK050306
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000040
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082871
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082944
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082864
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082843
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082863
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082866
Pays : United States
Investigateurs
Raymond T Chung
(RT)
Lewis R Roberts
(LR)
Mohamed A Hassan
(MA)
None Sarah Jane Schwarzenberg
David K Wong
(DK)
Joshua Juan
(J)
Colina Yim
(C)
Keyur Patel
(K)
Carol S Murakami
(CS)
Robert Perrillo
(R)
Norberto Rodriguez-Baez
(N)
Steven-Huy B Han
(SB)
David Geffen
(D)
Tram T Tran
(TT)
None Anna Suk-Fong Lok
Robert J Fontana
(RJ)
Barak Younoszai
(B)
Michael W Fried
(MW)
Andrew Muir
(A)
Donna Evon
(D)
Jama M Darling
(JM)
Robert C Carithers
(RC)
Margaret Shuhart
(M)
Kris V Kowdley
(KV)
Chia C Wang
(CC)
Karen F Murray
(KF)
Velimir A Luketic
(VA)
T Jake Liang
(T)
Jay H Hoofnagle
(JH)
Edward Doo
(E)
Kyong-Mi Chang
(KM)
Jang-June Park
(JJ)
Abdus Wahed
(A)
Yona Cloonan
(Y)
David Kleiner
(D)
Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Hepatology. 1999 Mar;29(3):976-84
pubmed: 10051506
J Trop Pediatr. 2000 Apr;46(2):121-3
pubmed: 10822942
N Engl J Med. 2002 Jul 18;347(3):168-74
pubmed: 12124405
J Virol. 2004 Aug;78(16):8524-35
pubmed: 15280461
JAMA. 2006 Jan 4;295(1):65-73
pubmed: 16391218
Hepatology. 2007 Aug;46(2):395-401
pubmed: 17628874
Hepatology. 2009 Sep;50(3):661-2
pubmed: 19714720
Gastroenterology. 2010 Apr;138(4):1357-64, 1364.e1-2
pubmed: 20064512
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4186-90
pubmed: 2034663
J Clin Microbiol. 2010 Nov;48(11):4161-8
pubmed: 20810764
J Viral Hepat. 2011 Jul;18(7):e179-83
pubmed: 21199189
Lancet Oncol. 2011 Jun;12(6):568-74
pubmed: 21497551
Hepatology. 2012 Aug;56(2):422-33
pubmed: 22105832
Clin Chem. 2012 May;58(5):854-68
pubmed: 22371482
Hepatology. 2013 Jan;57(1):399-408
pubmed: 22806323
Lancet. 2013 Feb 9;381(9865):468-75
pubmed: 23234725
BMJ Open. 2013 Aug 14;3(8):null
pubmed: 23945731
Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92
pubmed: 25010003
Lancet. 1989 Sep 9;2(8663):588-91
pubmed: 2570285
Hepatology. 2015 Jul;62(1):87-100
pubmed: 25808668
Hepatology. 2016 Feb;63(2):388-97
pubmed: 26251317
N Engl J Med. 2016 Jun 16;374(24):2324-34
pubmed: 27305192
Gastroenterology. 2016 Nov;151(5):986-998.e4
pubmed: 27453547
J Viral Hepat. 2017 Aug;24(8):679-686
pubmed: 28199770
Clin Chem Lab Med. 2018 Jun 27;56(7):1133-1139
pubmed: 29455185
JAMA. 1975 Jan 27;231(4):356-9
pubmed: 45864
Hepatology. 1984 Jul-Aug;4(4):608-10
pubmed: 6086483
Am J Epidemiol. 1977 Feb;105(2):94-8
pubmed: 835566
Epidemiol Infect. 1996 Oct;117(2):313-25
pubmed: 8870629
Virology. 1997 Jul 7;233(2):374-81
pubmed: 9217060
N Engl J Med. 1976 Oct 21;295(17):909-13
pubmed: 967200